Prognostic Impact of Angiotensin-Converting Enzyme Inhibitor Therapy in Diastolic Heart Failure

American Journal of Cardiology

Volumn 101, Issue 5, 2008, Pages 639-644

  Tribouilloy, Christophe ^a   Rusinaru, Dan ^a   Leborgne, Laurent ^a   Peltier, Marcel ^a   Massy, Ziad ^a   Slama, Michel ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; NITRATE; POTASSIUM SPARING DIURETIC AGENT;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIASTOLIC HEART FAILURE; FEMALE; HEART EJECTION FRACTION; HOSPITALIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SYSTOLIC HEART FAILURE; FOLLOW UP; HOSPITAL DISCHARGE; MULTIVARIATE ANALYSIS; SURVIVAL;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, DIASTOLIC; HUMANS; MALE; MULTIVARIATE ANALYSIS; PATIENT DISCHARGE; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 41949095557     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.10.026     Document Type: Article

References (30)

1. Owan T.E., Hodge D.O., Herges R.M., Jacobsen S.J., Roger V.L., and Redfield M.M. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355 (2006) 251-259
2. Zile M.R. Heart failure with preserved ejection fraction: is this diastolic heart failure?. J Am Coll Cardiol 4 (2003) 1519-1522
3. Yturralde R.F., and Gaasch W.H. Diagnostic criteria for diastolic heart failure. Prog Cardiovasc Dis 47 (2005) 314-319
4. Bhatia R.S., Tu J.V., Lee D.S., Austin P.C., Fang J., Haouzi A., Gong Y., and Liu P.P. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355 (2006) 260-269
5. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 325 (1991) 293-302
6. Pitt B., Zannad F., Remme W.J., Cody R., Castaigne A., Perez A., Palensky J., and Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341 (1999) 709-717
7. MERIT-HF Study Group. Effect of Metoprolol CR/XL in chronic heart failure. Metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 353 (1999) 2001-2007
8. Pfeffer M.A., McMurray J.J., Velazquez E.J., Rouleau J.L., Kober L., Maggioni A.P., Solomon S.D., Swedberg K., Van de Werf F., White H., et al., Valsartan in Acute Myocardial Infarction Trial Investigators. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349 (2003) 1893-1906
9. Yusuf S., Pfeffer M.A., Swedberg K., Granger C.B., Held P., McMurray J.J., Michelson E.J., Olofsson B., Ostergren J., and CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362 (2003) 777-781
10. Flather M., Shibata M., Coats A., Van Veldhuisen D.J., Parkhomenko A., Borbola J., Cohen-Solal A., Dumitrascu D., Ferrari R., Lechat P., et al., SENIORS Investigators. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admissions in elderly patients with heart failure (SENIORS). Eur Heart J 26 (2005) 215-225
11. Ahmed A., Rich M.W., Fleg J.L., Zile M.R., Young J.B., Kitzman D.W., Love T.E., Aronow W.S., Adams Jr. K.F., and Gheorghiade M. Effects of digoxin on morbidity and mortality in diastolic heart failure. The Ancillary Digitalis Investigation Group trial. Circulation 114 (2006) 397-403
12. Cleland J.G.F., Tendera M., Adamus J., Freemantle N., Polonski J., and Taylor J. The Perindopril in Elderly People with Chronic Heart Failure (PEP-CHF) study. Eur Heart J 27 (2006) 2238-2345
13. Swedberg K., Cleland J., Dargie H., Drexler H., Follath F., Komajda M., Tavazzi L., Smiseth O.A., Gavazzi A., Haverich A., et al., Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure executive summary (update 2005). The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
14. Philbin E.F., Rocco Jr. T.A., Lindenmuth N.W., Ulrich K., and Jenkins P.L. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am J Med 109 (2000) 605-613
15. Philbin E.F., and Rocco Jr. T.A. Use of angiotensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic function. Am Heart J 134 (1997) 188-195
16. Dauterman K.W., Go A.S., Rowell R., Gebretsadik T., Gettner S., and Massie B.M. Congestive heart failure with preserved systolic function in a statewide sample of community hospitals. J Card Fail 7 (2001) 221-228
17. Ahmed A., Roseman J.M., Duxbury A.S., Allman R.M., and DeLong J.F. Correlates and outcome of preserved left ventricular systolic function among older adults hospitalized with heart failure. Am Heart J 144 (2002) 365-372
18. Grigorian Shamagian L., Roman A.V., Ramos P.M., Veloso P.R., Bandin Dieguez M.A., and Gonzalez-Juanatey J.R. Angiotensin-converting enzyme inhibitors prescription is associated with longer survival among patients hospitalized for congestive heart failure who have preserved systolic function: a long-term follow-up study. J Card Fail 12 (2006) 128-133
19. Sueta C.A., Russo A., Schenck A., Brown D., and Simpson R.J. Effect of angiotensin-converting inhibitor or angiotensin receptor blocker on one-year survival in patients ≥65 years hospitalized with a left ventricular ejection fraction ≥50%. Am J Cardiol 91 (2003) 363-365
20. The Task Force on Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis of heart failure. Eur Heart J 16 (1995) 741-751
21. Vasan R.S., and Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 101 (2000) 2118-2121
22. Cheitlin M.D., Alpert J.S., Armstrong W.F., Aurigemma G.P., Beller G.A., Bierman F.Z., Davidson T.W., Davis J.L., Douglas P.S., and Gillam L.D. ACC/AHA guidelines for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on clinical application of echocardiography). Circulation 95 (1997) 1686-1744
23. Levey A.S., Coresh J., Greene T., Stevens L.A., Zhang Y.L., Hendriksen S., Kusek J.W., and Van Lente F. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med 145 (2006) 247-254
24. Remme W.J., and Swedberg K. Task force for the diagnosis and treatment of chronic heart failure. European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22 (2001) 1527-1560
25. Blackstone E.H. Analysis of death (survival analysis) and other time-related events. In: Macartney F.J. (Ed). Congenital Heart Disease (1986), MTP Press, Dodrecht 55-101
26. Joffe M.M., and Rosenbaum P.R. Invited commentary: propensity scores. Am J Epidemiol 150 (1999) 327-333
27. D'Agostino Jr. R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 12 (1998) 2265-2281
28. Hunt S.A., American College of Cardiology, and American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46 suppl (2005) e1-e82
29. Peltier M., Houpe D., Cohen-Solal A., Beguin M., Levy F., and Tribouilloy C. Treatment practices in heart failure with preserved left ventricular ejection fraction: a prospective observational study. Int J Cardiol 118 (2007) 363-369
30. Lenzen M.J., Scholte op Reimer W.J.M., Boersma E., Vantrimpont P.J., Follath F., Swedberg K., Cleland J., and Komajda M. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J 25 (2004) 1214-1220